Literature DB >> 8323953

An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen.

S M Moghimi1, H Hedeman, I S Muir, L Illum, S S Davis.   

Abstract

Earlier we demonstrated that coating the surface of large model polystyrene microspheres (220-300 nm in diameter) with the block co-polymer polyoxyethylene/polyoxypropylene poloxamine-908 triggered their accumulation in the rat spleen by a filtration mechanism following intravenous administration [Moghimi, S.M., Porter, C.J.H., Muir, I.S., Illum, L. and Davis, S.S. (1991) Biochem. Biophys. Res. Commun. 177, 861-866]. We have now demonstrated that the macrophages of the red-pulp can effectively phagocytose the filtered poloxamine-coated microspheres 24 h post-administration. This could be the result of either the loss of the surface absorbed poloxamine, and hence the steric barrier, or 'neutralization' of the effect of the anti-phagocytic material poloxamine-908 within the spleen. In order to assess the capacity of the splenic uptake mechanism(s), rats received daily intravenous administration of unlabelled large poloxamine-908 coated microspheres (220 nm in diameter) for 4 days (daily-dosed animals). Control rats received daily saline injection. On the fifth day all animals were injected with either radiolabelled large (220 nm) or small (60 nm in diameter) poloxamine-coated polystyrene microspheres. Predosing dramatically decreased the splenic uptake of the large test microspheres but had no effect on the uptake of small test-microspheres. The failure of the spleen to take up particles was not associated with an increased circulatory level of microspheres. Surprisingly, both small and large coated microspheres were sequestered by the liver and accumulated in Kupffer cells as demonstrated by electron microscopy in daily-dosed animals. In contrast, the liver of control animals did not effectively sequester poloxamine-coated microspheres. Here, microspheres predominantly remained in blood. Sequestration of poloxamine-908 coated microspheres by Kupffer cells of the liver of daily-dosed animals was the result of opsonization by an unknown serum component.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8323953     DOI: 10.1016/0304-4165(93)90105-h

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  26 in total

1.  Atrial natriuretic factor increases splenic microvascular pressure and fluid extravasation in the rat.

Authors:  R Sultanian; Y Deng; S Kaufman
Journal:  J Physiol       Date:  2001-05-15       Impact factor: 5.182

Review 2.  Strategies in the design of nanoparticles for therapeutic applications.

Authors:  Robby A Petros; Joseph M DeSimone
Journal:  Nat Rev Drug Discov       Date:  2010-07-09       Impact factor: 84.694

3.  Activation of the mononuclear phagocyte system by poloxamine 908: its implications for targeted drug delivery.

Authors:  T I Armstrong; S M Moghimi; S S Davis; L Illum
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

4.  Shape mediated splenotropic delivery of buparvaquone loaded solid lipid nanoparticles.

Authors:  Heena V Maithania; Bhabani S Mohanty; Pradip R Chaudhari; Abdul Samad; Padma V Devarajan
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

Review 5.  Nanocarriers for spleen targeting: anatomo-physiological considerations, formulation strategies and therapeutic potential.

Authors:  Anil B Jindal
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

6.  Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profiles.

Authors:  Marina A Dobrovolskaia; Anil K Patri; Jiwen Zheng; Jeffrey D Clogston; Nader Ayub; Parag Aggarwal; Barry W Neun; Jennifer B Hall; Scott E McNeil
Journal:  Nanomedicine       Date:  2008-12-13       Impact factor: 5.307

Review 7.  Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.

Authors:  Phatsapong Yingchoncharoen; Danuta S Kalinowski; Des R Richardson
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

8.  Polystyrene-poly (ethylene glycol) (PS-PEG2000) particles as model systems for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution.

Authors:  S E Dunn; A Brindley; S S Davis; M C Davies; L Illum
Journal:  Pharm Res       Date:  1994-07       Impact factor: 4.200

9.  Spleen capture of nanoparticles: influence of animal species and surface characteristics.

Authors:  M Demoy; J P Andreux; C Weingarten; B Gouritin; V Guilloux; P Couvreur
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

Review 10.  Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and intracellular delivery.

Authors:  Lilian E van Vlerken; Tushar K Vyas; Mansoor M Amiji
Journal:  Pharm Res       Date:  2007-03-29       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.